VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 84 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $333 | -32.3% | 43 | 0.0% | 0.00% | – |
| Q2 2023 | $492 | +48.2% | 43 | 0.0% | 0.00% | – |
| Q1 2023 | $332 | +26.7% | 43 | 0.0% | 0.00% | – |
| Q4 2022 | $262 | – | 43 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 43 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 43 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 43 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 43 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 43 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 43 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 43 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 43 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 43 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 43 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 43 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 43 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | – | 43 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 7,891,176 | $154,194,000 | 51.35% |
| Trustees of Princeton University | 203,638 | $3,979,000 | 4.13% |
| Casdin Capital, LLC | 1,135,000 | $22,178,000 | 3.10% |
| GREAT POINT PARTNERS LLC | 730,010 | $14,264,000 | 1.98% |
| BB BIOTECH AG | 2,532,641 | $49,488,000 | 1.43% |
| Aevitas Wealth Management, Inc. | 73,323 | $1,433,000 | 1.40% |
| Patriot Financial Group Insurance Agency, LLC | 64,256 | $1,256,000 | 1.34% |
| Virtus ETF Advisers LLC | 37,502 | $733,000 | 0.65% |
| Eventide Asset Management | 703,425 | $13,745,000 | 0.57% |
| THOMPSON DAVIS & CO., INC. | 11,951 | $234,000 | 0.56% |